Source: Benzinga

FierceBiotech: Questex's Fierce Biotech Summit Returns to Boston in October, Gathering the Industry's Most Influential Leaders to Discuss the Future of Biotech

NEW YORK, June 12, 2023 (GLOBE NEWSWIRE) -- Questex's Fierce Biotech, today announces the Fierce Biotech Summit, the only event that covers the entire pharma R&D spectrum, from basic research through clinical trials, will take place October 16-18 in Boston. Register here. "Following our successful inaugural 2022 event, we are excited to reconvene with the biotech community to discuss the future of the industry," said Ayla Ellison, Editor-in-Chief, Fierce Life Sciences and Healthcare. "The biotech landscape is rapidly evolving, and with each breakthrough we wonder what is next. The event will cover the use of AI in drug development, unique dealmaking strategies, the latest innovations in oncology and much more." The conference will cover drug development from the earliest stage of research to FDA approval and highlight the players involved in getting a drug from the lab to commercialization. Created by the editors behind Fierce Biotech, the conference will bring together over 600 biotech executives to network and learn how to improve partnerships and pipeline strategies. Event topics include: The Next Blockbuster Indications The Inflation Reduction Act (IRA): The Dawn of a New Era - What Will it Mean for Innovation? The Future of Oncology: Innovation and Advancements in the Biotech Industry Revolutionizing Drug Discovery and Development with AI: Maximizing Efficiency and Innovation in Biotech Success in the Middle of a Downturn: Strategies for Weathering the Biotech Storm and Building Trust ...Full story available on Benzinga.com

Read full article »
Est. Annual Revenue
$100K-5.0M
Est. Employees
500-1.0K
Kerry C. Gumas's photo - President & CEO of Fierce Biotech

President & CEO

Kerry C. Gumas

CEO Approval Rating

70/100

Read more